Cargando…
Blocking autophagy enhanced cytotoxicity induced by recombinant human arginase in triple-negative breast cancer cells
Depletion of arginine by recombinant human arginase (rhArg) has proven to be an effective cancer therapeutic approach for a variety of malignant tumors. Triple-negative breast cancers (TNBCs) lack of specific therapeutic targets, resulting in poor prognosis and limited therapeutic efficacy. To explo...
Autores principales: | Wang, Z, Shi, X, Li, Y, Fan, J, Zeng, X, Xian, Z, Sun, Y, Wang, S, Song, P, Zhao, S, Hu, H, Ju, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4454157/ https://www.ncbi.nlm.nih.gov/pubmed/25501824 http://dx.doi.org/10.1038/cddis.2014.503 |
Ejemplares similares
-
Recombinant human arginase induced caspase-dependent apoptosis and autophagy in non-Hodgkin's lymphoma cells
por: Zeng, X, et al.
Publicado: (2013) -
Autophagy deficiency promotes triple-negative breast cancer resistance to T cell-mediated cytotoxicity by blocking tenascin-C degradation
por: Li, Zhi-Ling, et al.
Publicado: (2020) -
Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy
por: Shi, W-Y, et al.
Publicado: (2012) -
A novel and promising therapeutic approach for NSCLC: recombinant human arginase alone or combined with autophagy inhibitor
por: Shen, Weitao, et al.
Publicado: (2017) -
SRGN-TGFβ2 regulatory loop confers invasion and metastasis in triple-negative breast cancer
por: Zhang, Z, et al.
Publicado: (2017)